Abstract
Extracorporeal shock wave lithotripsy and minimally invasive procedures for the management of urolithiasis are currently considered safe and effective. Yet, treatment-related hemorrhagic complications are common and at times dreadful. The risk of such complications is increased by the widely prevalent use of antiplatelet and anticoagulant medications as well as when operating on patients having inherited or acquired bleeding disorders. This chapter describes the perioperative management of these situations and depicts real-life scenarios of management of such cases.
Original language | English |
---|---|
Title of host publication | Urolithiasis |
Subtitle of host publication | Basic Science and Clinical Practice |
Publisher | Springer-Verlag London Ltd |
Pages | 557-561 |
Number of pages | 5 |
ISBN (Electronic) | 9781447143871 |
ISBN (Print) | 9781447143833 |
DOIs | |
Publication status | Published - 1 Jan 2012 |
Keywords
- Antiplatelet medication
- Coagulation disorders
- Hematological considerations
- Hemostatic defects